$4.98
0.142.89%
al cierre: -
$5.00
0.020.40%
After hour: 7:51 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Perspective Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 11
Estimación de BPA
$-0.320
Estimación de ingresos trimestrales
$244.10K
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
–
Analice el historial de beneficios de Perspective Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CATX | Perspective Therapeutics | -$0.21 | -$0.32 | — | — | $369.00K | $244.10K | — | — | 11/11/2025 | |
CATX | Perspective Therapeutics | -$0.17 | -$0.29 | -$0.30 | -3.45% | $526.00K | $242.22K | $290.00K | 19.72% | 08/13/2025 | |
CATX | Perspective Therapeutics | -$0.24 | -$0.27 | -$0.25 | 7.41% | $325.00K | $143.93K | $342.00K | 137.62% | 05/12/2025 | |
CATX | Perspective Therapeutics | -$0.90 | -$0.26 | -$0.60 | -130.77% | $2.03M | $302.51K | $234.00K | -22.65% | 03/26/2025 | |
CATX | Perspective Therapeutics | -$0.34 | -$0.21 | -$0.21 | 0.00% | $276.00K | $170.00K | $369.00K | 117.06% | 11/12/2024 | |
CATX | Perspective Therapeutics | -$0.34 | -$0.21 | -$0.17 | 19.05% | $588.00K | $60.00K | $526.00K | 776.67% | 08/12/2024 | |
CATX | Perspective Therapeutics | $0.00 | -$0.20 | -$0.20 | 0.00% | $233.00K | — | $325.00K | — | 05/15/2024 | |
CATX | Perspective Therapeutics | -$0.01 | — | -$0.90 | — | $2.50M | — | $2.03M | — | 03/28/2024 | |
CATX | Perspective Therapeutics | -$0.03 | -$0.40 | -$0.40 | 0.00% | $1.72M | $2.22M | $2.19M | -1.58% | 11/14/2023 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.30 | -$0.40 | -33.33% | $2.82M | $2.61M | $2.09M | -20.00% | 08/11/2023 | |
CATX | Perspective Therapeutics | -$0.02 | -$0.10 | $0.00 | 100.00% | $2.56M | $4.30M | $2.06M | -52.02% | 05/15/2023 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.02 | -100.00% | $2.82M | $4.20M | $1.83M | -56.31% | 02/16/2023 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.71M | $2.84M | $2.50M | -11.80% | 09/28/2022 | |
CATX | Perspective Therapeutics | -$0.01 | — | -$0.01 | — | $2.60M | $3.11M | $2.91M | -6.43% | 05/10/2022 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.36M | $2.95M | $2.82M | -4.54% | 02/08/2022 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.02 | -100.00% | $2.38M | $2.49M | $2.56M | 2.97% | 11/10/2021 | |
CATX | Perspective Therapeutics | -$0.02 | -$0.01 | -$0.01 | 0.00% | $2.28M | $2.75M | $2.71M | -1.45% | 09/21/2021 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.88M | $2.43M | $2.60M | 7.00% | 05/13/2021 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.21M | $2.39M | $2.36M | -1.30% | 02/09/2021 | |
CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.31M | $2.85M | $2.38M | -16.35% | 11/10/2020 |
Perspective Therapeutics (CATX) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-13 | $-0.30 | $-0.29 | -3.45 % |
| Q1 | 2025-05-12 | $-0.25 | $-0.27 | 7.41 % |
| Q4 | 2025-03-26 | $-0.60 | $-0.26 | -130.8 % |
| Q3 | 2024-11-12 | $-0.21 | $-0.21 | 0.00 % |
Perspective Therapeutics (CATX) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-13 | $290.00K | $242.22K | 19.7 % |
| Q1 | 2025-05-12 | $342.00K | $143.93K | 137.6 % |
| Q4 | 2025-03-26 | $234.00K | $302.51K | -22.7 % |
| Q3 | 2024-11-12 | $369.00K | $170.00K | 117.1 % |
PREGUNTAS FRECUENTES
¿Cuándo Perspective Therapeutics (AMEX:CATX) publicará los resultados?
Está previsto que Perspective Therapeutics (CATX) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 13, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Perspective Therapeutics (AMEX:CATX)?
El BPA real fue de $-0.30, que no alcanzó la estimación de $-0.29.
¿Cuáles fueron los ingresos de Perspective Therapeutics (AMEX:CATX)?
Los ingresos reales fueron $290K, que superó la estimación de $242.2K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.